Literature DB >> 26566263

Radiologic extranodal spread and matted nodes: Important predictive factors for development of distant metastases in patients with high-risk head and neck cancer.

Remco de Bree1,2, Redina Ljumanovic3, Marieke J Hazewinkel4, Birgit I Witte5, Jonas A Castelijns6.   

Abstract

BACKGROUND: Different clinical high-risk factors for the development of distant metastases have been identified but not tested in the same cohort of patients with head and neck squamous cell carcinoma (HNSCC).
METHODS: In 145 patients with previously identified clinical high risk factors, the presence of extranodal spread (ENS) and matted node on pretreatment CT (n = 96) and/or MRI (n = 111) were determined.
RESULTS: Of 145 patients, ENS was detected in 87 patients (60.0%) and matted nodes in 53 patients (36.6%). Kaplan-Meier curves for presence or absence of ENS (on CT and/or MRI) and matted nodes (on CT) differ significantly. In a Cox regression analysis, only ENS was a significant risk factor (hazard ratio [HR] = 3.3; 95% confidence interval [CI] = 2.0-5.5; p < .001).
CONCLUSION: In patients with high-risk HNSCC with clinically (palpably or radiologically) ENS and matted nodes, both determined radiologically, are high risk factors for development of distant metastases.
© 2015 Wiley Periodicals, Inc. Head Neck 38: E1452-E1458, 2016. © 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  distant metastases; extranodal spread; head and neck squamous cell carcinoma; matted nodes; risk factors

Mesh:

Year:  2015        PMID: 26566263     DOI: 10.1002/hed.24257

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  1 in total

1.  Predictive factors for simultaneous distant metastasis in head and neck cancer patients during the diagnostic work-up.

Authors:  Carlos Miguel Chiesa-Estomba; Maria Soriano-Reixach; Ekhiñe Larruscain-Sarasola; Jon Alexander Sistiaga-Suarez; Jose Angel González-García; Amaia Sanchez-Martin; Laura Basterretxea-Badiola; Naiara Sagastibelta; Xabier Altuna-Mariezcurrena
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-02-07       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.